Hongming Zhuang – författare

This issue of PET Clinics focuses on PET Imaging in Pediatric Patients and is edited by Drs. Hongming Zhuang and Abass Alavi. Articles will include: Promising New PET tracers in the evaluation of pediatric disease; F-DOPA PET/CT in the management of congenital hyperinsulinism; Emerging roles of PET/MRI in pediatric hospital; Roles of FDG PET/CT in the management of posttransplant lymphoproliferative disease in pediatric patient; FDG-PET/CT in the management of pediatric lymphoma; Preparation and logistic consideration in performing PET/CT and PET/MRI in pediatric patients; PET/CT in the evaluation of FUO and infectious/inflammatory disease in pediatric patients; Roles of PET/CT in the evaluation of neuroblastoma; Potential Roles of Total Body Imaging in Pediatric Diseases and Disorders; PET/CT in the Management of Pediatric Sarcomas; Pediatric Cardiac PET Imaging; Dosimetry between PET/CT and PET/MRI: Implications in Pediatric Imaging; Essential Role of Global Disease Assessment in Assessing Systemic Disorders, and more!

In this issue of PET Clinics, guest editors Drs. Hongming Zhuang and Abass Alavi bring their considerable expertise to the topic of PET/MRI for the Pediatric Patient. Tops experts cover key topics such as application of PET/MRI in the assessment of inflammatory and infection disease in pediatric patients; PET/MRI in the evaluation of lymphomas and post-transplant lymphoproliferative disorder in pediatric patients; evaluation of congenital hyperinsulinism using 18F-FDOPA positron emission tomography; management of pediatric brain tumors with aid of PET/MRI; and much more.

Now that the applications of positron emission tomography (PET) are becoming more clearly understood, PET is now being used in pediatric population. Important considerations in its use on children are patient preparation and radiation exposure. This issue reviews the use of PET to image children with Hodgkin and non-Hodgkin lymphoma, brain tumors, and inflammatory bowel disease, among other conditions. Also included is the use of PET to assess response to therapy.